131 related articles for article (PubMed ID: 6889916)
1. A review of etoposide in patients with non-small-cell lung cancer (NSCLC).
Itri LM; Gralla RJ
Cancer Treat Rev; 1982 Jun; 9 Suppl():115-8. PubMed ID: 6889916
[No Abstract] [Full Text] [Related]
2. Etoposide alone and in combination with cyclophosphamide, adriamycin and cis-platinum in patients with Mo and Mi non-small-cell lung cancer.
Eagan RT
Cancer Treat Rev; 1982 Jun; 9 Suppl():119-31. PubMed ID: 6889917
[No Abstract] [Full Text] [Related]
3. Etoposide as single agent and in combination chemotherapy of bronchogenic carcinoma.
Goldhirsch A; Joss R; Cavalli F; Brunner KW
Cancer Treat Rev; 1982 Jun; 9 Suppl():85-90. PubMed ID: 6290057
[No Abstract] [Full Text] [Related]
4. Etoposide and cis-platinum in non-small-cell bronchogenic carcinoma.
Klastersky J; Longeval E; Nicaise C; Weerts D
Cancer Treat Rev; 1982 Jun; 9 Suppl():133-8. PubMed ID: 6889918
[No Abstract] [Full Text] [Related]
5. Combination cis-platinum and etoposide in small-cell lung cancer.
Natale RB; Wittes RE
Cancer Treat Rev; 1982 Jun; 9 Suppl():91-4. PubMed ID: 6290058
[No Abstract] [Full Text] [Related]
6. Treatment of inoperable non-small-cell bronchogenic carcinoma with etoposide and cis-platinum.
Mitrou PS; Fischer M; Weissenfels I; Diehl V; Gropp C; Liesenfeld A; Schmidt M; Berdel WE; Fink U; Graubner M
Cancer Treat Rev; 1982 Jun; 9 Suppl():139-42. PubMed ID: 6889919
[No Abstract] [Full Text] [Related]
7. Combination chemotherapy with cisplatin, etoposide, and vindesine in non-small cell lung carcinoma: a clinical trial of the EORTC lung cancer working party.
Klastersky J; Sculier JP; Nicaise C; Weerts D; Mairesse M; Libert P; Rocmans P; Michel J; Ferremans W
Cancer Treat Rep; 1983; 67(7-8):727-30. PubMed ID: 6347374
[TBL] [Abstract][Full Text] [Related]
8. Etoposide--an effective single drug for treating bronchogenic carcinoma.
Anderson G; Peel ET; Cheong CM; Broderick NJ
Clin Oncol; 1982; 8(3):215-8. PubMed ID: 7140048
[No Abstract] [Full Text] [Related]
9. [Treatment of anaplastic carcinoma of the lung with VP 16-213].
Sanz Ortíz J; Saiz García F
Med Clin (Barc); 1982 Oct 16-31; 79(7):322-4. PubMed ID: 6294420
[No Abstract] [Full Text] [Related]
10. VP16-213 combined with cis-platinum (CDDP) in the treatment of small cell carcinoma of the lung (SCLC).
Madrigal PA; Manga GP; Palomero I; Gomez RG
Cancer Chemother Pharmacol; 1982; 7(2-3):203-4. PubMed ID: 6282485
[No Abstract] [Full Text] [Related]
11. Combination chemotherapy of small-cell bronchogenic carcinoma with etoposide (VP-16), ifosfamide and vindesine (VPIV), and with adriamycin, cis-platinum and vincristine (APO).
Havemann K
Cancer Treat Rev; 1982 Jun; 9 Suppl():95-100. PubMed ID: 6290059
[No Abstract] [Full Text] [Related]
12. [Combination of etoposide with cisplatin or cyclophosphamide in the treatment of mouse Lewis lung carcinoma].
Uchida T; Okamoto K; Nishikawa K; Takahashi K
Gan To Kagaku Ryoho; 1986 Jan; 13(1):75-9. PubMed ID: 3753643
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of etoposide, vincristine, and high-dose cisplatin in advanced non-small cell lung cancer.
Bertrand M; Multhauf P; Presant C; Rappaport D; Blayney DW; Carr BI; Cecchi G; Doroshow JH; Emont E; Goldberg D
Cancer Treat Rep; 1985 Nov; 69(11):1335-6. PubMed ID: 4092199
[No Abstract] [Full Text] [Related]
14. Etoposide (VP-16) in the treatment of lung cancer.
Pedersen AG; Hansen HH
Cancer Treat Rev; 1983 Dec; 10(4):245-64. PubMed ID: 6318994
[No Abstract] [Full Text] [Related]
15. Etoposide as single agent and in combination with cis-platinum for malignant lymphomas.
Kroner T; Obrecht JP; Jungi WF
Cancer Treat Rev; 1982 Jun; 9 Suppl():39-43. PubMed ID: 6889920
[No Abstract] [Full Text] [Related]
16. [Phase II study of etoposide in patients with lung cancer, with special reference to small cell carcinoma].
Kurita Y; Yokoyama A; Kinameri K; Matsuura N; Sano K
Nihon Gan Chiryo Gakkai Shi; 1986 Feb; 21(1):108-11. PubMed ID: 3009665
[No Abstract] [Full Text] [Related]
17. Etoposide (VP-16-213).
Issell BF; Crooke ST
Cancer Treat Rev; 1979 Jun; 6(2):107-24. PubMed ID: 385138
[No Abstract] [Full Text] [Related]
18. MACC (methotrexate, doxorubicin, cyclophosphamide and lomustine) versus cis-platinum and etoposide in the treatment of advanced non-small cell lung cancer.
Buccheri G; Ferrigno D; Curcio A; Vola F; Mattalia E
Chemioterapia; 1986 Feb; 5(1):53-7. PubMed ID: 3955784
[TBL] [Abstract][Full Text] [Related]
19. Etoposide after ACO treatment for small-cell bronchogenic carcinoma.
Essers U; Knechten H; Seelis R; Ammon J
Cancer Treat Rev; 1982 Jun; 9 Suppl():111-3. PubMed ID: 6290054
[No Abstract] [Full Text] [Related]
20. Does etoposide have curative potential?
Ignoffo RJ
Clin Pharm; 1983; 2(2):167. PubMed ID: 6309470
[No Abstract] [Full Text] [Related]
[Next] [New Search]